Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

November 30, 2005

Study Completion Date

August 31, 2008

Conditions
Lung Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

topotecan hydrochloride

RADIATION

WBRT

Trial Locations (24)

20060

MBCCOP-Howard University Cancer Center, Washington D.C.

32224

Mayo Clinic, Jacksonville

48106

CCOP - Ann Arbor Regional, Ann Arbor

55416

CCOP - Metro-Minnesota, Saint Louis Park

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Health Plaza, Saint Cloud

57709

Rapid City Regional Hospital, Rapid City

58122

CCOP - Merit Care Hospital, Fargo

58201

Altru Health Systems, Grand Forks

58501

Medcenter One Health System, Bismarck

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

70121

CCOP - Ochsner, New Orleans

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

Wichita Community Clinical Oncology Program, Wichita

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

15212-4772

Allegheny General Hospital, Pittsburgh

S4T 7T1

Allan Blair Cancer Centre, Regina

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00028925 - Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter